AF
CLB icon

Amalgamated Financial’s Core Laboratories CLB Stock Holding History

Amalgamated Financial’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$482K Buy
+15,242
New +$427K ﹤0.01% 1525

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
CPH
C Partners Holding Zurich, Switzerland $317M AUM 4.76% 1-Year Est. Return

Amalgamated Financial's CLB Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Core Laboratories (CLB) in Q1 2022: 15,242 shares worth $482K. The stake represents ﹤0.01% of the portfolio and ranks #1525 among its holdings.

196 funds tracked by Wall St. Rank hold CLB as of Q1 2022.

  • Amalgamated Financial held 15,242 shares of Core Laboratories worth $482K as of Q1 2022.
  • Core Laboratories was a new Amalgamated Financial position in Q1 2022.
  • Core Laboratories made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1525 holding.
  • 196 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.